- Home
- WFCF vs SER Comparison
WFCF vs SER Comparison
Compare WFCF & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFCF
- SER
- Stock Information
- Founded
- WFCF 1996
- SER 2017
- Country
- WFCF United States
- SER United States
- Employees
- WFCF N/A
- SER N/A
- Industry
- WFCF Computer Software: Prepackaged Software
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- WFCF Technology
- SER Health Care
- Exchange
- WFCF Nasdaq
- SER Nasdaq
- Market Cap
- WFCF 60.2M
- SER 54.3M
- IPO Year
- WFCF 2011
- SER 2018
- Fundamental
- Price
- WFCF $11.19
- SER $5.17
- Analyst Decision
- WFCF
- SER
- Analyst Count
- WFCF 0
- SER 0
- Target Price
- WFCF N/A
- SER N/A
- AVG Volume (30 Days)
- WFCF 5.2K
- SER 17.4K
- Earning Date
- WFCF 11-12-2024
- SER 11-12-2024
- Dividend Yield
- WFCF N/A
- SER N/A
- EPS Growth
- WFCF 13.22
- SER N/A
- EPS
- WFCF 0.36
- SER N/A
- Revenue
- WFCF $25,815,000.00
- SER $3,156,637.00
- Revenue This Year
- WFCF N/A
- SER N/A
- Revenue Next Year
- WFCF N/A
- SER N/A
- P/E Ratio
- WFCF $30.48
- SER N/A
- Revenue Growth
- WFCF 5.38
- SER 2436.14
- 52 Week Low
- WFCF $9.76
- SER $3.81
- 52 Week High
- WFCF $13.95
- SER $23.18
- Technical
- Relative Strength Index (RSI)
- WFCF 49.03
- SER 37.60
- Support Level
- WFCF $10.84
- SER $5.00
- Resistance Level
- WFCF $11.50
- SER $5.76
- Average True Range (ATR)
- WFCF 0.27
- SER 0.77
- MACD
- WFCF -0.03
- SER -0.14
- Stochastic Oscillator
- WFCF 47.70
- SER 34.39
About WFCF Where Food Comes From Inc.
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including IMI Global, International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.